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Prolonged changes in neuronal activity trigger compensatory modifications in synaptic function to restore
firing rates to normal levels. In this issue of Neuron, Aoto et al. demonstrate that synthesis of retinoic acid
offsets chronic network inactivity by increasing synaptic strength through upregulation of GluR1 receptors.Modulation of synaptic transmission in re-
sponse to specific patterns of neuronal
firing underlies the storage of memory
traces in the mammalian CNS. Thus, un-
derstanding how synaptic connections
are preserved andmodified is of particular
importance. Interestingly, decreasing ac-
tivity in a neuron before synapse forma-
tion leads to a reduction in functional
synaptic inputs to that neuron. Reducing
activity in a single neuron after synapses
are established, however, leads to a com-
pensatory increase in synaptic inputs that
tends to restore the neuronal firing to
‘‘normal’’ levels (Burrone et al., 2002).
Keeping neuronal activity within an opti-
mal range is thought to be necessary for
safeguarding information processing
capabilities.
Homeostatic plasticity has often been
studied by means of pharmacological
manipulations that block neuronal firing
and/or synaptic transmission in cultured
neurons (Turrigiano et al., 1998). Chroni-
cally decreasing the activity of a network
triggers a quantitative change in synaptic
strength, typically involving an increase
in the size of the unitary synaptic current
produced by a single quantum of released
transmitter. This quantal amplitude is re-
flected by the amplitude of spontaneous
miniature excitatory postsynaptic cur-
rents (mEPSCs) and has been attributed
to an increased number of AMPA recep-
tors in the postsynaptic membrane. To
a first approximation, the regulation can
be conceptualized as a uniform multipli-
cation of the strength of individual synap-
ses, which would preserve the relative
strengths of synapses while scaling the
intensity of the overall synaptic input to
within useful bounds (Turrigiano and Nel-
son, 1998).
Adaptation to inactivity can also involve
qualitative changes in the properties of192 Neuron 60, October 23, 2008 ª2008 Elssynaptic transmission that could funda-
mentally alter the way that neurons
perform computations. In addition to in-
creasing the total number of postsynaptic
AMPA-type glutamate receptors, pro-
longed blockade of activity can also trig-
ger an adaptive switchover from GluR2-
containing (Ca2+-impermeable) receptors
to homomeric GluR1 (Ca2+-permeable)
receptors (Thiagarajan et al., 2007).
Changing the relationship between gluta-
mate release and Ca2+ influx will in turn
alter the neuron’s ability to undergo fur-
ther synaptic plasticity, a phenomenon
known as metaplasticity. Expression of
homeostatic synaptic adaptation is not
the exclusive monopoly of postsynaptic
elements. For example, presynaptic
changes in the probability of vesicular re-
lease can also occur as a consequence of
activity blockade (see Thiagarajan et al.,
2007 for references).
Three signalingmolecules have recently
gainedattention for their role in expression
of homeostatic plasticity following activity
blockade: the b isoform of Ca2+ and
calmodulin-dependent protein kinase II
(b-CaMKII), the immediate early gene
product Arc/Arg3.1, and the cytokine tu-
mor necrosis factor-a (TNFa) (Thiagarajan
et al., 2007; Shepherd et al., 2006; Stell-
wagen and Malenka, 2006). Blockade of
neuronal activity increases the expression
of bCaMKII within neurons (Thiagarajan
et al., 2007) and TNFa within glial cells
(Stellwagen andMalenka, 2006). Individu-
ally, b-CaMKII and TNFa both have been
shown to increase synaptic strength by
increasing surface expression of GluR2-
lacking AMPA receptors (M. Lindskog,
T.C. Thiagrajan, and R.W.T., unpublished
data; Stellwagen and Malenka, 2006).
Expression of Arc/Arg3.1 is dramatically
decreased by activity blockade, thereby
dampening its ability to trigger endocyto-evier Inc.sis of AMPA receptors, with the overall
effect of increasing surface GluR1 recep-
tors (Shepherd et al., 2006). Despite the
aforementioned progress, a comprehen-
sive understanding of this kind of synaptic
regulation remains elusive.
In this issue ofNeuron, Aoto et al. (2008)
provide compelling evidence for a novel
pathway in homeostatic adaptation to
inactivity involving retinoic acid (RA), the
biologically active derivative of vitamin A
(retinol), and its receptor RARa. Best
known for its role in regulating neural de-
velopment, RA has recently emerged as
an important signaling molecule and
regulator of synaptic plasticity in the adult
CNS as well. For example, vitamin A dep-
rivation prevents long-term potentiation
(LTP) and reduces long-term depression
(LTD) in the hippocampus (Maden,
2002). Adding to this growing literature,
Aoto and colleagues (2008) found that
acute application of RA increasedmEPSC
amplitude in both cultured hippocampal
slices and dissociated hippocampal cul-
tures, suggesting that RAmay be involved
in homeostatic plasticity. Because RA is
a lipophilic molecule that can directly
pass through cell membranes, regulation
of its synthesis is all-important for its sig-
naling function. RA is derived from vitamin
A in two oxidative steps: first, the conver-
sion of retinol to retinal by retinol dehydro-
genases (RoDHs), and second, the
oxidation of retinal to RA by retinal dehy-
drogenases (RALDHs). Blocking RA syn-
thesis with inhibitors of either RoDH or
RALDH prevented the inactivity-induced
increase in mEPSC amplitude elicited by
24 hr blockade of excitability and NMDA
receptor function. Furthermore, such ac-
tivity blockade occluded the ability of RA
to increase mEPSC amplitude, implicat-
ing endogenous RA in the adaptation to
inactivity.
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nal activity increases RA synthesis, Aoto
et al. (2008) turned to a reporter construct
that reads out RA activation of nuclear RA
receptors (RARs) by putting multiple RA
response elements in control of the tran-
scription of GFP. They found that blocking
neuronal activity increased GFP expres-
sion in transfected neurons, implying
that inactivity triggers synthesis of RA.
Furthermore, when HEK293 cells trans-
fected with the GFP-based reporter were
plated with activity-deprived neurons, in-
creased expression of GFP was also ob-
served, confirming that RA can act as
a membrane-permeant messenger. Aoto
and colleagues (2008) attributed the RA
production to neurons (rather than glia)
because they found strong RALDH1 im-
munoreactivity in neurons, extending out
into the neurites.
To explore the role of RA in adaptation
to inactivity, Aoto et al. (2008) sought to
determine how RA increased mEPSC
amplitude. They demonstrated that RA
increased surface GluR1 expression and
that a blocker of GluR2-lacking AMPA
receptors abolished the RA-induced in-
crease inmEPSCamplitude. Interestingly,
RA was able to increase surface GluR1
expression in the presence of a transcrip-
tional inhibitor, but not a protein synthesis
inhibitor, suggesting that RA may trigger
local translation of GluR1. Consistent with
this notion, Aoto and colleagues (2008)
demonstrated that RA increased GluR1
protein levels in synaptoneurosomes,
a preparation that lacks cell nuclei.
In lieu of the canonical RA regulation of
transcription, Aoto and colleagues (2008)
looked for a nonconventional pathway
for homeostatic compensation. Immu-
nostaining showed that the RA receptor
RARa was localized within dendrites as
well as the nucleus (see also Chen and
Napoli, 2008). To test whether RARa me-
diates the acute effects of RA on synaptic
transmission, Aoto et al. (2008) used an
shRNA strategy to reduce the levels of
RARa. RARa knockdown prevented RA
from increasing GluR1 expression and
mEPSC amplitude, while the effects
were rescued by expression of an
shRNA-resistant RARa. In addition, appli-
cation of a selective RARa agonist reca-
pitulated the effects of RA. Accordingly,
Aoto and colleagues (2008) propose that
RARa senses the inactivity-generatedRA, causing in turn an upregulation of
GluR1 receptors and increased synaptic
strength.
It is often the case that experiments that
point to an unprecedented role for a sig-
naling molecule end up raising as many
questions as they answer. This study by
Aoto et al. (2008) is no exception. The fol-
lowing is a brief discussion of the most in-
triguing issues.
How Does Inactivity Increase
the Level of RA?
The findings of Aoto et al. (2008) focus
attention on the control points for RA
synthesis in neurons. To explain the low
ambient level of RA within neurons, indi-
cated by their GFP reporter data, Aoto
and colleagues (2008) focused on
RALDH1, the enzyme that makes RA, as
the target of modulation by activity-depri-
vation. However, the available evidence is
also compatible with regulation of RoDH,
since this upstream enzyme is also critical
for the pathway leading to RA production.
Control of RoDHwould be consistent with
(1) the ability of the RoDH inhibitor citral to
prevent the synaptic adaptation and (2)
the already high basal levels of RALDH1
protein, which suggests that RALDH1
might not be the biochemical bottleneck.
Whichever enzyme is rate limiting, a
pressing question is how its activity might
be linked to the function of NMDA recep-
tors. Given that NMDAR blockade by
APV (in addition to impulse blockade by
TTX) was necessary to trigger an increase
in RA, the key enzymemight be negatively
regulated by NMDAR-mediated Ca2+
entry in dendritic spines. This would fit
nicely with the finding that NMDA recep-
tors activated by spontaneous synaptic
transmission suffice to suppress local
GluR1 synthesis (Sutton et al., 2006). Fi-
nally, the activity of the RA-metabolizing
enzyme, CYP26A1 (cytochrome p450,
26) should be examined to complete the
picture of how RA is regulated.
Where Is RA Produced and Where
Does It Act?
Given that RA is a membrane-permeable
signaling molecule, it could potentially
act in a paracrine or autocrinemanner, de-
pending on where it is synthesized and
where its target is located. RA-mediated
paracrine communication between cells
would mesh well with mounting evidenceNeuron 60that adaptation to inactivity is not purely
cell autonomous but can involve trans-
synaptic signaling. For example, decreas-
ing activity in a postsynaptic cell through
expression of an inwardly-rectifying po-
tassium channel (Kir2.1) causes changes
in presynaptic vesicle turnover (Burrone
et al., 2002). Conversely, suppression of
presynaptic activity by use of the same K
channel increasespostsynapticGluR1ex-
pression (Hou et al., 2008). Both findings
illustrate how a sensor of activity on one
side of the synapse may drive compensa-
tory changes expressed on the other side.
Clearly, such effects require cell-cell com-
munication, but the nature of themessage
remains obscure. Whether RA or some
other diffusible messenger participates in
trans-synaptic crosstalk between neurons
remains to be tested.
The data of Aoto et al. (2008) seem
more consistent with an autocrine action
of RA. The most obvious site of RA pro-
duction is the postsynaptic cell itself,
where the signal from NMDA receptors
originates. Likewise, the RA-induced
increases in surface GluR1 immunoreac-
tivity and mEPSC amplitude all fit with
a simple postsynaptic target mecha-
nism—a local action of RA within the
same cell where it was produced. It might
seem ironic if a potentially powerful trans-
membrane signaling molecule was simply
used as a classical intracellular messen-
ger. However, there is a precedent for
this. Nitric oxide generated in response
to NMDA receptor activation regulates
AMPA receptor trafficking via local cy-
clases and kinases (Serulle et al., 2007):
thus, a membrane-permeant agent may
act on an identified target within the
same cell in which it is synthesized.
At present, a combination of autocrine
and paracrine actions cannot be ex-
cluded. The use of RA over different
ranges may be dependent on the nature
of the change in activity levels as well as
the identity of the synapses involved in
the adaptation. For example, RA is a
candidate retrograde messenger at hip-
pocampal synapses where adaptation to
inactivity involves clear presynaptic
modifications, such as the mossy fiber-
CA3 synapse (Kim and Tsien, 2008).
Determining the origin and target of RA
signaling will be essential to further under-
standing of its functional significance. The
recruitment of a membrane-permeable, October 23, 2008 ª2008 Elsevier Inc. 193
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ing questions about the local or global na-
ture of the signal. It will be interesting to
work out the consequences of a readily
diffusible messenger that drives local pro-
tein translation and what this implies for
synapse and dendritic specificity.
How Does RARa Signal to Increase
Translation of GluR1?
It is now well accepted that dendrites
have the capacity for local synthesis of
proteins. Aoto and colleagues (2008)
have presented convincing evidence that
RARa triggers local translation of GluR1,
but the mechanism by which this occurs
is unclear. Although the classical role of
RARa is that of a transcription factor, its
implication in rapid, nongenomic signal-
ing should come as no surprise. Indeed,
many other members of the nuclear hor-
mone receptor superfamily, including ste-
roid hormone receptors, have been
shown to mediate rapid actions, indepen-
dent of gene expression regulation, via
conventional second messenger cas-
cades. It remains to be determined
whether RARa induces GluR1 synthesis
by co-opting a signaling cascade already
known to regulate translation or through
a novel mechanism. Intriguingly, RARa
has been detected within RNA granules
(Chen et al., 2008), suggesting that an
even more unconventional mechanism
might be at play.
How Does RA Fit in with Other
Candidates for Molecular Players
in Adaptation to Inactivity?
Given that RA, bCaMKII, and TNFa each
induce upregulation of GluR1 postsynap-194 Neuron 60, October 23, 2008 ª2008 Eltically (and consequently increased quan-
tal amplitude), we appear to have an
embarrassment of riches in the form of
multiple signaling candidates. Thorny is-
sues regarding differences in induction
protocols, timescale, and source(s) of
the various messengers may help ac-
count for the lack of an obvious link be-
tween RA, b-CaMKII, and TNFa. For ex-
ample, while blocking action potentials
with TTX is sufficient to increase expres-
sion of b-CaMKII and TNFa, upregulation
of RA requires the additional blockade of
NMDA responses with APV. Further, while
expression of b-CaMKII and RA is in-
creased within 24 hr, upregulation of
TNFa requires activity-deprivation for at
least 48 hr. On the other hand, potential
overlaps do exist. TNFa triggers insertion
of GluR1 in the membrane through activa-
tion of the phosphoinositide 3-kinase
(PI3K) signaling pathway. Likewise, RA
can activate PI3K signaling (for example,
see Masia´ et al., 2007), so activation of
this pathway may be a shared target.
Delving into the details of the respective
mechanisms may yet reveal additional
ways that these signaling pathways may
synergize with each other. In conclusion,
Aoto et al. (2008) have presented strong
evidence that RA andRARa, agents previ-
ously known for biological actions of
a very different kind are critical for synap-
tic adaptation to inactivity. Understanding
the logic of their involvement will be ad-
vanced by focusing on how NMDARs
generate RA production, how RARa acti-
vation is linked to delivery of GluR1, and
whether a potentially diffusible messen-
ger must cross cell membranes to carry
out its job.sevier Inc.ACKNOWLEDGMENTS
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